Immuron Ltd (IMRN) SEC Filing 6-K Foreign Issuer report for the period ending Friday, October 4, 2019

Immuron Ltd

CIK: 1660046 Ticker: IMRN

View differences made from one to another to evaluate Immuron Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Immuron Ltd.


Assess how Immuron Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Immuron Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Immuron Ltd provided additional information to their SEC Filing as exhibits

Ticker: IMRN
CIK: 1660046
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001213900-19-019685
Submitted to the SEC: Fri Oct 04 2019 6:12:20 AM EST
Accepted by the SEC: Fri Oct 04 2019
Period: Friday, October 4, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: